Cue Biopharma (CUE) Current Leases (2019 - 2025)
Cue Biopharma (CUE) posted Current Leases of $1.9 million for Q4 2025, down 5.91% sequentially from $2.0 million in Q3 2025, and down 46.02% YoY from $3.5 million in Q4 2024.
Cue Biopharma (CUE) Current Leases (2019 - 2025) Analysis & Trends
Cue Biopharma has reported Current Leases for 7 years, with the latest figure at $1.9 million in Q4 2025.
- Quarterly Current Leases fell 46.02% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (down 46.02% YoY) and the FY2025 annual result came in at $1.9 million, down 46.02% from the prior year.
- Current Leases retreated to $1.9 million in Q4 2025 per CUE's latest filing, from $2.0 million in the prior quarter.
- Over five years, Current Leases peaked at $5.4 million in Q1 2022 and troughed at $100300.0 in Q4 2022.
- A 5-year average of $3.3 million and a median of $3.4 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases sank 97.97% in 2022, then soared 3257.93% in 2023.
- Over 5 years, Current Leases stood at $4.9 million in 2021, then tumbled by 97.97% to $100300.0 in 2022, then jumped by 3257.93% to $3.4 million in 2023, then increased by 5.11% to $3.5 million in 2024, then sank by 46.02% to $1.9 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $1.9 million, $2.0 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 3.58 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Dec 31, 2023 | 3.37 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 3.37 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 100,300.00 |
| Sep 30, 2022 | 3.34 Mn |
| Jun 30, 2022 | 3.20 Mn |
| Mar 31, 2022 | 5.39 Mn |
| Dec 31, 2021 | 4.93 Mn |
| Sep 30, 2021 | 3.63 Mn |
| Jun 30, 2021 | 4.87 Mn |
| Mar 31, 2021 | 4.99 Mn |